CARDINAL HEALTH INC financial data

Symbol
CAH on NYSE
Location
Dublin, OH
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.17 % -1.3%
Quick Ratio 44.66 % -2.4%
Return On Equity -62.65 % -63.9%
Return On Assets 3.11 % +9.5%
Operating Margin 1.01 % +23.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 237,595,042 shares -1.8%
Entity Public Float 28,372,319,280 USD +16.2%
Common Stock, Value, Issued 2,746,000,000 USD -2.9%
Weighted Average Number of Shares Outstanding, Basic 238,000,000 shares -2.1%
Weighted Average Number of Shares Outstanding, Diluted 239,000,000 shares -2.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 234,310,000,000 USD +4.4%
Operating Income (Loss) 2,375,000,000 USD +28.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2,158,000,000 USD +20.8%
Income Tax Expense (Benefit) 552,000,000 USD +9.3%
Net Income (Loss) Attributable to Parent 1,595,000,000 USD +24.6%
Earnings Per Share, Basic 1.89 USD/shares +10.5%
Earnings Per Share, Diluted 1.88 USD/shares +10.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4,593,000,000 USD +60.2%
Inventory, Net 17,559,000,000 USD +12.4%
Other Assets, Current 2,602,000,000 USD +0.42%
Assets, Current 38,537,000,000 USD +17.1%
Property, Plant and Equipment, Net 2,831,000,000 USD +11.7%
Operating Lease, Right-of-Use Asset 758,000,000 USD +59.6%
Intangible Assets, Net (Excluding Goodwill) 2,399,000,000 USD +44.3%
Goodwill 9,711,000,000 USD +1.1%
Other Assets, Noncurrent 1,750,000,000 USD +42.2%
Assets 55,228,000,000 USD +28.3%
Accounts Payable, Current 36,860,000,000 USD +21.4%
Liabilities, Current 40,268,000,000 USD +16.1%
Long-term Debt and Lease Obligation 8,980,000,000 USD +1.1%
Operating Lease, Liability, Noncurrent 654,000,000 USD +63.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -159,000,000 USD -2.6%
Retained Earnings (Accumulated Deficit) 1,116,000,000 USD +78.7%
Stockholders' Equity Attributable to Parent -2,879,000,000 USD +12.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2,731,000,000 USD +16.6%
Liabilities and Equity 55,228,000,000 USD +28.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 973,000,000 USD
Net Cash Provided by (Used in) Financing Activities -110,000,000 USD +79.6%
Net Cash Provided by (Used in) Investing Activities -142,000,000 USD -61.4%
Common Stock, Shares Authorized 755,000,000 shares 0%
Common Stock, Shares, Issued 271,000,000 shares -17.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 719,000,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4,593,000,000 USD +60.2%
Deferred Tax Assets, Valuation Allowance 254,000,000 USD -15.3%
Deferred Tax Assets, Gross 1,230,000,000 USD -17.5%
Operating Lease, Liability 818,000,000 USD +58.2%
Payments to Acquire Property, Plant, and Equipment 108,000,000 USD +20%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1,591,000,000 USD +23.3%
Property, Plant and Equipment, Gross 7,516,000,000 USD +12.3%
Operating Lease, Liability, Current 164,000,000 USD +40.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 500,000 shares 0%
Unrecognized Tax Benefits 894,000,000 USD -6.1%
Amortization of Intangible Assets 322,000,000 USD +20.1%
Depreciation, Depletion and Amortization 233,000,000 USD +28%
Share-based Payment Arrangement, Expense 121,000,000 USD -0.82%
Interest Expense 263,000,000 USD +2.7%